The mission of Chelsea’s Hope is to improve the lives of those affected by Lafora Disease and help accelerate the development of treatments.
Chelsea’s Hope Lafora Children Research Fund is an IRS 501(c)3 non-profit organization. EIN: 27-1008382
Chelsea’s Hope, Post Office Box 348626, Sacramento, CA 95834
Lafora In The News
/by Riley HawkinsThroughout the last month or so, Chelsea’s Hope and Lafora disease have been in the news quite a few times. Keep reading to learn about and find links to each one!
Articles
Patient Worthy
James Moore
July 28, 2023
In Patient Worthy’s new series about rare disease education, James Moore details Lafora disease in easy-to-understand bullet points. Without a doubt, it is a wonderful resource for learning the basic information and impact of Lafora.
Dementia Alliance International
Niki Markou
July 20, 2023
Dementia Alliance International helps to spread the word of Fighting The Rare, including a brief summary of Niki Markou (A.K.A. our Director of Family Support) and Angelina’s experiences with Lafora.
Eurordis
July 2023
Featured in this article are two Lafora disease patients: Angelina and Robin. In essence, their mothers, Niki Markou and Veronique Gadomski (from France Lafora), tell their stories. While there are similarities between their experiences, it is evident that each Lafora patient and their family has their own unique stories – each and everyone worth learning about!
Patient Worthy
James Moore
August 4, 2023
Our partner, Patient Worthy, gives readers a list of the international scientists that took part in Fighting The Rare, accompanied by a brief explanation of Lafora Disease.
Videos
CheckRare
June 22, 2023
With their spotlight on Fighting The Rare, CheckRare (a rare disease organization) gives an explanation in scientific terms of what causes Lafora disease. Additionally, this article includes a video of Niki Markou and Jordi Duran (Ph.D., Associate Professor at Institut Químic de Sarrià in Barcelona) talking through their roles and aspirations during the creation of Fighting The Rare.
CheckRare
June 23, 2023
In CheckRare’s second Lafora disease-focused article in June, they delve into the common symptoms of Lafora, and hypothesize about a possible treatment. Also highlighted in this article is a Youtube video of Niki Markou and Jordi Duran discussing Lafora disease symptoms and pathophysiology.
Podcast
Vibe Bio
Hosted by Ray Dogum with guest Niki Markou
July 13, 2023
If you’re looking for something to listen to regarding news on Lafora disease, you can check out the latest VibeCast featuring Niki and Dr. Duran! Host Ray Dogum from Vibe Bio asks about Lafora disease, living with symptoms, research, hope for treatments, and the recent Fighting the Rare documentary. It is out now on Youtube and Spotify.
2023 Symposium Registration is Open Now!
/by Christine KellyWe are delighted to announce that the 2023 Symposium registration is open now.
Please join us October 9-10, 2023, in the beautiful and historic city of Bologna.
Lafora disease researchers and clinicians at the Instituto delle Scienze Neurologiche di Bologna IRCCS will host the 8th Annual Lafora Disease Science Symposium at the Relais Bellaria. You can read more details about the city and venue on our webpage!
This conference is ideal for families affected by Lafora disease, researchers, healthcare professionals, and our industry partners. The 2022 Lafora Disease Science Symposium in San Diego was a great time of collaboration, learning, and advancement toward treatments for Lafora. We would love to meet you in Italy!
Register for the 2023 Lafora Disease Science Symposium!
Please note: Chelsea’s Hope is hosting the 2023 Symposium registration until September 15. Please register individually to attend the in-person Symposium. If you can’t make it in person, we encourage you to register and indicate your interest in receiving the recordings after the conference.
The 2023 Symposium registration will close in two months, so don’t wait!
Probably Genetic Program: FAQs
/by Christine KellyFAQs about Probably Genetic’s no-cost genetic testing program for pediatric epilepsy
Who is Probably Genetic?
Probably Genetic is a group of patients, geneticists, and engineers that seek to make genetic testing more accessible to rare disease patients. Their team partners with patient advocacy groups, such as Chelsea’s Hope, and biotech companies to launch no-cost genetic testing programs to end the diagnostic odyssey.
Probably Genetic allows caregivers of pediatric epilepsy patients to access a genetic testing option from the comfort of their homes. Their process eliminates the need to find the right specialist and is free of charge to the patient. Also, their approach empowers the individual and provides an easy way to get the answers you’ve been looking for.
What is Probably Genetic’s program?
Probably Genetic has launched a genetic testing program specifically for individuals experiencing seizure or developmental delay-related disorders. It was designed with a highly sensitive approach and was built in collaboration with communities of affected individuals and their care partners.
You will receive a saliva kit in the mail with a return label to send the equipment back or picked up from your home by USPS if you’re eligible. Once analyzed, all pathogenic, likely pathogenic, and variants of uncertain significance associated with the patient’s documented symptoms are reported, even if the mutations found aren’t related to a seizure disorder like Lafora disease. The entire process is free for families. We encourage caregivers to submit to the program for their loved one, too.
Please note: Testing is available only in the United States.
How do patients apply?
Complete a brief, patient and family-friendly online symptom checker to see if you’re eligible. Individuals who qualify for no-cost testing based on their submission are notified via email. Afterward, a testing kit is sent to their home address. The test only requires a saliva sample, which is returned to the lab using a prepaid shipping box for convenience. Our support team can also schedule a USPS pick-up time for you. We encourage caregivers to submit and collect samples for their loved ones.
What happens to the results?
Probably Genetic is the custodian of all patient data submitted through their programs, meaning they never share identifiable patient information with third parties without consent. They follow strict HIPAA guidelines and their entire testing pipeline is CLIA and CAP accredited. They completely de-identify any data or learnings from the program before sharing them with any third party, meaning that it is impossible to identify the source of the submission. You can access all your information via a unique patient portal, where you can also opt for your sequencing results to be given to your physicians. Results are only shared with physicians if patients explicitly request for this to happen.
Is this a clinical trial?
The no-cost testing program is not a clinical trial. Probably Genetic does not test therapies or interventions. They also do not conduct research. However, de-identified information generated by the programs can help advocacy groups and biotech companies better understand the patient experience for those living with rare and ultra-rare conditions. Examples include insights on the average wait for a diagnosis or the average symptom profile for a given condition. Families can further rare disease knowledge and potentially discover the cause of their loved one’s symptoms by participating in this program.
How can I determine my child’s eligibility?
Complete the Probably Genetic Symptom Checker for Pediatric Seizure Conditions!
You can also refer to our announcement about our partnership with Probably Genetic. Also, you might find answers on their FAQs page.
Probably Genetic Partnership Announcement
/by Christine KellyChelsea’s Hope partners with Probably Genetic to identify Lafora disease patients
Chelsea’s Hope Lafora Children Research Fund is excited to announce our new collaboration with Probably Genetic as a patient-finding partner for our community. If you or anyone you know is looking for a trusted genetic testing resource, Probably Genetic runs a no-cost, low barrier testing program for individuals experiencing seizure and developmental delay-related disorders.
Read more on the Probably Genetic Partnership
Probably Genetic is a group of geneticists, engineers, and patients seeking to help people with rare diseases access genetic testing. The company has recently launched a no-cost genetic testing program for people with seizure or developmental delay-related disorders. Eligible individuals can receive whole exome sequencing at no cost. This testing analyzes all of the protein-coding regions of your DNA for disease-causing mutations.
We are looking forward to reducing the diagnostic odyssey of many patients through our Probably Genetic partnership.
Genetic Testing Eligibility
To participate, candidates must reside in the United States. Take a brief, easy-to-understand online quiz to determine your eligibility for the program. Also, caregivers, friends, or family members are encouraged to submit on behalf of their loved one if their loved one cannot complete the Symptom Checker without assistance.
How it works
The Probably Genetic team is always open to feedback so the program is as successful as possible for the Lafora disease community!
Fighting the Rare Documentary
/by Christine KellyRelease date June 26, 2023
Fighting the Rare is a documentary offering a glimpse into research on Lafora disease through the testimonies of researchers, patients, and their relatives.
Why Lafora disease?
Lafora Disease is a rare neurodegenerative condition affecting children. It is terminal; there is no cure. Healthy children first show symptoms in their early teens, epilepsy followed by cognitive decline, and typically die within 10 years. Lafora disease is ultra-rare, with around only 80 registered children affected in the world and a suspected 200-300 patients worldwide.
Research on Lafora Disease is an example of how a disease can be studied, from its discovery to obtaining the first treatments. In Fighting the Rare, using family stories and the study of Lafora as a backbone, general concepts related to biology and medicine, diseases, the scientific process, and the importance of research are explained. It is a must-watch for the rare disease and health community.
Who is in the documentary?
The documentary was created by Dr. Jordi Duran, Dr. Jaume Duran, and César Valdivia, who collaborated with a worldwide network of people fighting Lafora disease, including these researchers: Dr. Berge A. Minassian (the University of Texas Southwestern Medical Center); Dr. José María Serratosa (Institute for Health Research F. Jiménez Díaz); Dr. Matthew S. Gentry (University of Florida); and Dr. Joan J. Guinovart (Biomedical Research Institute); Dr. Salvador Borrós and Dr. Cristina Fornaguera (Chemical Institute of Sarrià). They interviewed two families telling their stories: Niki Markou from Sydney, Australia; Jenifer and Mariah Merriam from Arizona, USA.
Want to share this news with your community? Download the toolkit now! Sharing the documentary will help raise awareness about Lafora and other rare diseases.
We are so excited to watch the documentary!
Social Media Toolkit
Fighting the Rare Webpage
Fighting the Rare Trailer
An Update on Alexis | #WarriorWednesday
/by Christine KellyAn update on Alexis was provided by Kim Marino on May 16, 2023:
“Alexis has been stable for the last couple of months but just recently within the last couple of weeks seizure activity has picked up a great deal. The seizure activity has led to behavior problems which is understandable. Though we haven’t had any gran mal seizures we are having a lot of myoclonics. Alexis hasn’t been able to even stand as much as she has been in the past couple of weeks. Her verbal communication has become worse. Now that summer is here we will try and get her out as often as possible to enjoy the weather and family.”
Alexis May 2023
Alexis and AC
Alexis and family enjoying the sun
As Alexis’s Lafora disease symptoms continue progressing, helping her access an experimental treatment is more important than ever. Her team of doctors, including geneticists and neurologists, has applied for FDA approval for the emergency use of medication to target the glycogen buildup in her muscles. However, Alexis’s insurance company will not cover the cost of this treatment, even though it could slow down the pace of this disease and give Alexis a fighting chance. Her mother, AC, started a GoFundMe for Alexis in December 2022. 100% of the proceeds will go towards the cost of this medication and any additional expenses that may be incurred during the process. You can donate to become one of Alexis’s Angels today and share her story with everyone you know!
June Research Roundtable Registration
/by Christine KellyWhen? It will be Thursday, June 22, 2023, from 10:30 am – 12:00 pm EST.
Where? The Roundtable will be virtual. You can register to attend via Zoom!
We will be hearing from experts on clinical markers in Lafora Disease. Like the April Roundtable, there will be presentations and ideally time for discussion at the end.
Families are welcome to attend and ask questions, so we hope you will be able to join us for this event! We recommend that you refer to Science Terms 101 if you are not a researcher or clinician attending. It’s full of helpful definitions of scientific terms you might hear. You can download the PDF and print it out for your reference!
The Roundtable is only one month away, so register today!
Also, please register if you are interested but you are unsure if you can attend or not! We will email a summary of the Roundtable to everyone who registered. It will also be posted on our Research Roundtable page.
Chelsea’s Hope is excited about our June Research Roundtable. Please contact us if you have any questions.
Lafora Disease Science Terms 101
/by Christine KellyWe’ve just published the helpful PDF filled with Lafora Disease Science Terms that you can download for your own use or to share.
Our community benefits from a number of dedicated research champions who work alongside our families to find a cure for this devastating disease. There is a lot that we can learn about Lafora disease from our scientists. As you read their scientific publications and listen to their presentations, please refer to the Science Terms 101 publication for terms that will help you understand their research.
Lafora Bodies
For example:
Glycogen: When our bodies have extra sugar (glucose), they store it in the form of glycogen, which is made up of a bunch of sugars linked together. Our bodies use sugars to make fuel for our cells (the way that gasoline or electricity fuel a car). When your body needs energy quickly, it can remove the sugar from this storage device and use it for fuel.
Protein-Coding Gene: A piece of DNA that contains instructions for synthesizing a protein. Patients with Lafora Disease have mutations in one of two genes:
1. EPM2A: the gene with instructions for making the protein laforin.
2. EPM2B (also called NHLRC1): the gene with instructions for making the protein malin.
Besides glycogen and proteins, Lafora Disease Science Terms 101 includes definitions for biomarkers, knock-in and knock-out mouse models, and more! Get your copy today.
Thank you to Chelsea’s Hope Science Director Dr. Kit Donohue, for defining the terms.